Bryant Wendy, Greenfield Jerry R, Chisholm Donald J, Campbell Lesley V
Diabetes Centre, St Vincent's Hospital, Sydney, NSW, Australia.
Med J Aust. 2006 Sep 18;185(6):305-9. doi: 10.5694/j.1326-5377.2006.tb00583.x.
To review the management of glycaemia, blood pressure and serum lipids in a hospital outpatient diabetes clinic, the director of which co-authored the current national diabetes management guidelines.
Retrospective audit.
Outpatient diabetes clinic in a tertiary referral teaching hospital, Sydney, NSW.
96 patients with type 1 diabetes (mean age, 44.4 [SD, 12.8] years) and 509 patients with type 2 diabetes (mean age, 64.4 [SD, 12.0] years) attending the clinic in 2003, who had undergone formal review of complications.
Weight, height, control and treatment of glycaemia, blood pressure and serum lipids, and prevalence of diabetic microvascular complications.
Glycated haemoglobin (HbA(1c)) was < 7% in 13% of type 1 and 30% of type 2 diabetes patients, and > 8% in 47% and 34%, respectively. 35% of patients with type 1 diabetes and 71% of patients with type 2 diabetes were treated with antihypertensive agents. Of these patients, 29% and 24%, respectively, had blood pressure readings </= 130/80 mmHg. Among patients not treated with hypertensive agents, blood pressure readings were </= 130/80 mmHg in 60% of type 1 and 38% of type 2 diabetes patients. About 30% of patients with type 1 diabetes and 50% of those with type 2 diabetes were being treated with lipid-lowering agents; of these, about 60% had low-density lipoprotein (LDL) cholesterol levels < 2.6 mmol/L. Among patients not treated with lipid-lowering agents, about 40% had LDL cholesterol levels < 2.6 mmol/L. Retinopathy was documented in 52% and 18%, and nephropathy in 9% and 36% of type 1 and type 2 diabetes patients, respectively.
Despite the demonstrated benefits of tight glucose, blood pressure and lipid control in reducing the risk of macrovascular and microvascular complications in type 1 and type 2 diabetes, our results suggest that treatment targets are not being met in a large proportion of patients attending a tertiary referral hospital. Responsible practice suggests that treatment targets and the current means to achieve them should both be examined.
回顾一家医院门诊糖尿病诊所的血糖、血压和血脂管理情况,该诊所主任参与撰写了当前的国家糖尿病管理指南。
回顾性审计。
新南威尔士州悉尼一家三级转诊教学医院的门诊糖尿病诊所。
2003年在该诊所就诊、接受过并发症正式评估的96例1型糖尿病患者(平均年龄44.4[标准差12.8]岁)和509例2型糖尿病患者(平均年龄64.4[标准差12.0]岁)。
体重、身高、血糖、血压和血脂的控制与治疗情况,以及糖尿病微血管并发症的患病率。
13%的1型糖尿病患者和30%的2型糖尿病患者糖化血红蛋白(HbA1c)<7%,分别有47%和34%的患者HbA1c>8%。35%的1型糖尿病患者和71%的2型糖尿病患者接受了抗高血压药物治疗。在这些患者中,血压读数≤130/80 mmHg的分别占29%和24%。在未接受抗高血压药物治疗的患者中,60%的1型糖尿病患者和38%的2型糖尿病患者血压读数≤130/80 mmHg。约30%的1型糖尿病患者和50%的2型糖尿病患者正在接受降脂药物治疗;其中,约60%的患者低密度脂蛋白(LDL)胆固醇水平<2.6 mmol/L。在未接受降脂药物治疗的患者中,约40%的患者LDL胆固醇水平<2.6 mmol/L。1型和2型糖尿病患者中视网膜病变的记录率分别为52%和18%,肾病的记录率分别为9%和36%。
尽管严格控制血糖、血压和血脂在降低1型和2型糖尿病大血管和微血管并发症风险方面已显示出益处,但我们的结果表明,在一家三级转诊医院就诊的大部分患者中,治疗目标并未实现。合理的做法是,应同时审视治疗目标和当前实现这些目标的方法。